A recent study explored a new way to treat certain patients with head and neck cancer. The researchers tested whether ...
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new ...
One of the youngest victims of proposed NIH funding cuts would be six-year-old Cailen Vela of Michigan, who has a rare and ...
Eikon’s lead candidate EIK1001 is being investigated for melanoma in combination with MSD’s Keytruda in a Phase III trial.
Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...